Scott Braunstein | Chief Executive Officer |
Sasha Damouni | Vice President, Investor Relations and Corporate Communications |
Joe Hulihan | Chief Medical Officer |
Christy Shafer | Chief Commercial Officer |
Steve Pfanstiel | Chief Financial Officer |
Kimberly McCormick | Vice President, Regulatory Affairs |
Christy Shafer | Chief Commercial Office |
Joseph Thome | Cowen & Company |
Joon Lee | Truist Securities |
Douglas Tsao | H.C. Wainwright |
Andrew Tsai | Jefferies |
Marc Goodman | SVB Leerink |
Nina | Cantor Fitzgerald |
Brian Skorney | Baird |
Jay Olson | Oppenheimer |
Greetings and welcome to the Marinus Pharmaceuticals Second Quarter 2021 Business Update Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. [Operator Instructions]. And now it is my pleasure to introduce your host, Sasha Damouni Ellis, Vice President of Corporate Affairs and Investor Relations.